Back to Screener

Healthcare

Gyre Therapeutics, Inc.(GYRE)

Live Price

Offline

$6.21

-4.17% today

1Y Change

-15.65%

Window

Jun 25, 2025 โ†’ Jun 18, 2026

Market Cap
$740.00M
Revenue Growth
+10.2%
EPS Growth
-59.8%
Dividend Yield
0.0%

Coverage: 247 bars ยท Jun 25, 2025 โ†’ Jun 18, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Gyre Therapeutics, Inc. (GYRE) is a Healthcare stock with a market cap of $740.00M and listed on NASDAQ. The stock last traded around $6.21 and down 15.7% across the available one-year price window (Jun 25, 2025 โ†’ Jun 18, 2026). Baseline metrics include revenue growth of +10.2%, EPS growth of -59.8%, a dividend yield of 0.0%. What stands out right now is revenue +10.2%, EPS -59.8%, free cash flow +97.3% with operating margin 9.9% and ROIC 5.3%. Valuation already assumes a fairly strong business story at P/E 139.3 and price/sales 6.4. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines GYRE price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Edge

GYRE vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

GYRE

โ€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

GYRE Max Drawdown

-37.32%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for GYRE and SPY.

Calendar-year return history is still loading or unavailable.

Earnings Reports

๐Ÿ“… Last reportedMay 8, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”Report
โ€”
May 8, 26
โ€”
Est -0.07
โ€”
โ€”
Est 31606.7B
โ€”
May 8
โ€”
Mar 12, 26
โœ—
0.04
Est 0.06
-29.4%
37195.0B
Est 35433.3B
+5.0%
Mar 12
โ€”
Nov 7, 25
โœ“
0.06
Est 0.05
+20.0%
30564.0B
Est 36303.3B
-15.8%
Nov 7
โ€”
Aug 11, 25
โœ—
0.02
Est 0.03
-33.3%
26771.0B
Est 34300.0B
-21.9%
Aug 11
โ€”
May 9, 25
โ€”
0.03
Est 0.03
0.0%
22058.0B
Est 28700.0B
-23.1%
May 9
โ€”
Mar 17, 25
โœ—
0.01
Est 0.04
-75.0%
27872.0B
Est 23500.0B
+18.6%
Mar 17
โ€”
Nov 13, 24
0.02
Est โ€”
โ€”
25488.0B
Est โ€”
โ€”
Nov 13
โ€”
Aug 13, 24
0.01
Est โ€”
โ€”
25225.0B
Est 113450.0B
-77.8%
Aug 13
โ€”
May 9, 24
0.04
Est โ€”
โ€”
27172.0B
Est โ€”
โ€”
May 9
โ€”
Mar 26, 24
โœ—
-0.68
Est -0.60
-13.6%
29981.9B
Est โ€”
โ€”
Mar 26
โ€”
Oct 26, 23
โœ—
-1.05
Est -0.75
-40.0%
30735.8B
Est โ€”
โ€”
Oct 26
โ€”
Aug 14, 23
โ€”
-0.07
Est -0.07
0.0%
26135.7B
Est โ€”
โ€”
Aug 14
โ€”
May 15, 23
โœ“
0.14
Est -1.05
+113.5%
24437.3B
Est โ€”
โ€”
May 15
โ€”
Mar 30, 23
โœ“
-0.05
Est -1.57
+96.5%
794.0B
Est 400.0B
+98.5%
Mar 30
โ€”
Nov 14, 22
โœ“
-0.05
Est -1.50
+96.3%
29170.0B
Est โ€”
โ€”
Nov 14
โ€”
Aug 15, 22
โœ“
0.08
Est -3.67
+102.1%
23333.1B
Est โ€”
โ€”
Aug 15
โ€”
May 9, 22
0.08
Est โ€”
โ€”
794.0B
Est โ€”
โ€”
May 9
โ€”
Mar 31, 22
โœ“
-0.65
Est -6.85
+90.5%
2440.0B
Est 797.0B
+206.2%
Mar 31
โ€”
Nov 12, 21
-0.80
Est โ€”
โ€”
2299.0B
Est โ€”
โ€”
Nov 12
โ€”
Aug 5, 21
-0.64
Est โ€”
โ€”
1132.0B
Est โ€”
โ€”
Aug 5
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.

Read the earnings calendar guideOpen the calendar screener